ANTH - Anthera Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.1M
Enterprise Value 3-6.95M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.20
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 60.19

Trading Information

Stock Price History

Beta (3Y Monthly) 4.70
52-Week Change 3-51.78%
S&P500 52-Week Change 30.90%
52 Week High 30.1000
52 Week Low 30.0100
50-Day Moving Average 30.0503
200-Day Moving Average 30.0759

Share Statistics

Avg Vol (3 month) 348.59k
Avg Vol (10 day) 327.17k
Shares Outstanding 521.48M
Float 26.13M
% Held by Insiders 10.18%
% Held by Institutions 13.21%
Shares Short (Jun 15, 2018) 42.02M
Short Ratio (Jun 15, 2018) 42.09
Short % of Float (Jun 15, 2018) 410.45%
Short % of Shares Outstanding (Jun 15, 2018) 47.70%
Shares Short (prior month May 15, 2018) 41.43M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 28/1
Last Split Date 3May 1, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Mar 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-141.96%
Return on Equity (ttm)-568.85%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-28.49M
EBITDA -36.4M
Net Income Avi to Common (ttm)-24.93M
Diluted EPS (ttm)-1.7640
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.09M
Total Cash Per Share (mrq)0.31
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)3.30
Book Value Per Share (mrq)0.21

Cash Flow Statement

Operating Cash Flow (ttm)-31.95M
Levered Free Cash Flow (ttm)-17.92M